Transcode Therapeutics Inc.
13F holders, Q1 2024 (March 31)7holders
$0.68avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Transcode Therapeutics Inc. in their 13F filings. The largest holders were Sabby Management, LLC ($229K), Virtu Financial LLC ($37K) and Two Sigma Securities, LLC ($15K).
- Company
- Transcode Therapeutics Inc.
- CUSIP
- 89357L303
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $284K |
| Exits | 1 | $8K |
Ownership 7 holders
| Sabby Management, LLC | 1.65% | New | 334,823 | $229K |
| Virtu Financial LLC | 0.00% | New | 55,329 | $37K |
| Two Sigma Securities, LLC | 0.00% | New | 21,975 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 4,927 | $3K |
| Wells Fargo & Company | 0.00% | New | 5 | $3 |
| First Personal Financial Services | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is TRANSCODE THERAPEUTICS INC's weight in each manager's 13F, not the share of Transcode Therapeutics Inc. the manager owns.